Short answer · Medically reviewed summary · Last updated: 2023-07-13
Systemic Primary Carnitine Deficiency (SPCD) is a rare genetic disorder that affects the body's ability to transport long-chain fatty acids into the cells for energy production. It is caused by mutations in the SLC22A5 gene, which encodes a protein called carnitine transporter OCTN2.
Is Systemic Primary Carnitine Deficiency hereditary?
Is Systemic Primary Carnitine Deficiency hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Systemic Primary Carnitine Deficiency (SPCD) is a rare genetic disorder that affects the body's ability to transport long-chain fatty acids into the cells for energy production. It is caused by mutations in the SLC22A5 gene, which encodes a protein called carnitine transporter OCTN2. This protein is responsible for the uptake of carnitine from the bloodstream into the cells.
SPCD is indeed hereditary and follows an autosomal recessive pattern of inheritance. This means that both parents must carry a copy of the mutated gene for their child to be affected. If both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit two copies of the mutated gene and develop SPCD.
Individuals with SPCD typically present with symptoms such as low levels of carnitine in the blood, muscle weakness, cardiomyopathy, and hypoglycemia. If left untreated, SPCD can lead to severe complications, including heart problems and liver dysfunction.
Diagnosis of SPCD is usually confirmed through genetic testing, which identifies mutations in the SLC22A5 gene. Additionally, blood tests can measure carnitine levels to assess deficiency.
Treatment for SPCD involves lifelong carnitine supplementation to restore normal carnitine levels in the body. This helps improve energy production and prevent the progression of symptoms. Regular monitoring of carnitine levels and overall health is essential to ensure optimal management of the condition.
In conclusion, Systemic Primary Carnitine Deficiency is a hereditary disorder caused by mutations in the SLC22A5 gene. It follows an autosomal recessive pattern of inheritance and can lead to various symptoms if left untreated. Early diagnosis through genetic testing and prompt initiation of carnitine supplementation are crucial for managing the condition effectively.
